3 Healthcare & Biotech Stocks up over 32% past 10 days
Powered by HealthTechMovers.com
Below is a list of 3 Healthcare & Biotech Stocks up over 32% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Clarus Therapeutics Holdings, CRXT
Summary: Clarus Therapeutics Inc. is a specialty pharmaceutical company which provide solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women. The Company's commercial product includes JATENZO(R). Clarus Therapeutics Inc., formerly known as Blue Water Acquisition Corp., is based in NORTHBROOK, Ill.
Ticker | Company | Sector | Previous Close | *Recent Price | % Price Change Past 10 Days |
CRXT | Clarus Therapeutics Holdings | Healthcare & Biotech | $2.08 | $2.44 | +73% |
Here are 3rd party ratings for CRXT:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR and mesenchymal-like adherent stromal cells targeting indications across cancer, infectious and degenerative diseases. Celularity Inc., formerly known as GX Acquisition Corp., is based in NEW YORK.
Ticker | Company | Sector | Previous Close | *Recent Price | % Price Change Past 10 Days |
CELU | Celularity | Healthcare & Biotech | $12.39 | $12.57 | +35% |
Here are 3rd party ratings for CELU:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Lyra Therapeutics Inc. is a clinical-stage therapeutics company. It is focused on the development and commercialization of novel integrated drug and delivery solutions for patients with ear, nose and throat diseases. The company's proprietary technology platform, XTreo(TM), is designed to precisely and consistently deliver medicines directly to the affected tissue. Its initial product candidates consist LYR-210 and LYR-220 which are in clinical stage. Lyra Therapeutics Inc. is based in Watertown, Mass.
Ticker | Company | Sector | Previous Close | *Recent Price | % Price Change Past 10 Days |
LYRA | Lyra Therapeutics | Healthcare & Biotech | $5.42 | $5.51 | +32% |
Here are 3rd party ratings for LYRA:
|
What’s the sentiment on the street? Current ratings compiled by TipRanks.com)
|
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------